In this episode, the focus is on significant shifts in the AI landscape. The episode begins with a look at the stock market turmoil and DeepSeek's AI breakthrough, setting the stage for a discussion on the global tech landscape transformation. Michelle highlights Google's strategy of democratizing AI by making its Gemini 2.5 Pro model free, examining its implications. The conversation extends to Zhipu AI's introduction of a free agent and its performance benchmarks. In the realm of healthcare, the episode explores Weill Cornell's use of AI in precision medicine, specifically in cancer treatment models. The episode concludes with insights into AI's role in personalized cancer treatment and future visions for the field.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related